Key facts
- This page summarizes John E. Kao's Form 4 filing for Alignment Healthcare, Inc. (ALHC).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 02 Aug 2022, 21:18.
John E. Kao - 01 Aug 2022 Form 4 Insider Report for Alignment Healthcare, Inc. (ALHC)
- Reporting relationship
- Chief Executive Officer, Director
- Issuer ticker
- ALHC
- Reported as of
- 01 Aug 2022
- Net transaction value
- -$730,094
- SEC form
- 4
- Accepted by SEC
- 02 Aug 2022, 21:18:13 UTC
- Prior SEC filing
- 11 Jul 2022
- Next SEC filing
- 09 Aug 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Richard A. Cross, as Attorney-in-Fact, for John E. Kao
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
John E. Kao filed Form 4 for Alignment Healthcare, Inc. (ALHC) on 02 Aug 2022.
Change
- Previous filing in this sequence was filed on 11 Jul 2022.
- Current net transaction value: -$730,094.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ALHC
transaction
Common Stock
Sale
- Transaction value
- $717,595
- Shares
- -49,152
- Change %
- -1.4%
- Price
- $14.60
- Shares after
- 3,416,239
- Date
- 01 Aug 2022
- Ownership
- See Footnote
- Footnotes
- F1, F2
ALHC
transaction
Common Stock
Sale
- Transaction value
- $12,500
- Shares
- -848
- Change %
- -0.02%
- Price
- $14.74
- Shares after
- 3,415,391
- Date
- 02 Aug 2022
- Ownership
- See Footnote
- Footnotes
- F1, F2
ALHC
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 781,353
- Date
- 01 Aug 2022
- Ownership
- Direct
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
Footnote F2
Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.